PPTA | Immunoglobulin Literature Database
Home
Contact us
- - - - - - -
News/archive
Literature database
Cardiology
Dermatology
Guidelines
Haematology
Infectious Diseases
Internal Medicine
Neonatology
Nephrology
Neurology
Obstetrics
Paediatrics
Pulmonology
Rheumatology
Miscellaneous
PID
Multiple sclerosis
Title Filter
Display #
5
10
15
20
25
30
50
100
All
#
Article Title
1
Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of ch
2
Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a random
3
Long term safety of IVIg therapy in multiple sclerosis: 10 years experience.
4
Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosis.
5
Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multi
6
European study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfe
7
Increased blood plasma concentrations of TGF-beta isoforms after treatment with intravenous immunogl
8
Increased blood plasma concentrations of TGF-beta isoforms after treatment with intravenous immunogl
9
Intravenous immunoglobulin and mitoxantrone stop the progression of secondary progressive multiple s
10
A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination w
11
The role of qualitative and quantitative MRI assessment of multiple sclerosis lesions according to t
12
Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlle
13
Regulation of self-reactive T cells by human immunoglobulins--implications for multiple sclerosis th
14
Contrasting effects of IFNbeta and IVIG in children with central and peripheral demyelination.
15
[Intravenous immunoglobulins for relapsing-remitting multiple sclerosis after failure of treatment w
16
[Intravenous immunoglobulin in multiple sclerosis]
17
Intravenous immunoglobulins for multiple sclerosis.
18
Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials.
19
The role of intravenous immunoglobulin in the treatment of multiple sclerosis.
20
Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-ana
<<
Start
<
Prev
1
2
Next
>
End
>>
Page 1 of 2
FIND-ID
Regulators
FDA
EMEA